Host-pathogen interactions and the pathogenesis of murine Lyme disease

Current Opinion in Rheumatology

Volumn 14, Issue 4, 2002, Pages 399-403

  Weis, Janis J ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BINDING PROTEIN; CD4 ANTIGEN; CELL ADHESION MOLECULE; COLLAGEN; DECORIN; GENE PRODUCT; INTEGRIN; LIPOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MEMBRANE PROTEIN; SCLEROPROTEIN; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR;

ALLELE; ANTIGENIC VARIATION; B LYMPHOCYTE; BACTERIAL GENE; BORRELIA BURGDORFERI; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; LYME DISEASE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ANIMAL; DISEASE MODEL; GENETICS; IMMUNOLOGY; INFECTIOUS ARTHRITIS; INNATE IMMUNITY; MICROBIOLOGY; MOUSE; PATHOGENICITY;

ANIMAL; ARTHRITIS, INFECTIOUS; BORRELIA BURGDORFERI; DISEASE MODELS, ANIMAL; IMMUNITY, NATURAL; LYME DISEASE; MICE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS;

EID: 0035985861     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200207000-00011     Document Type: Review

References (53)

1. Lyme disease
2. Lyme disease: A review of aspects of its immunology and immunopathogenesis
3. The clinical evolution of Lyme arthritis
4. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice
5. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis
6. Lyme borreliosis in selected strains and ages of laboratory mice
7. Lyme disease: A tick-borne spirochetosis?
8. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency
9. Host-pathogen interactions promoting inflammatory Lyme arthritis: Use of mouse models for dissection of disease processes
10. Borrelia burgdorferi genes selectively expressed in the infected host
11. Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice
12. An immune evasion mechanism for spirochetal persistence in lyme borreliosis
13. Regulation of OspE-related, OspF-related, and Elp lipoproteins of Borrelia burgdorferi strain 297 by mammalian host-specific signals
14. Distinct reguratory pathways control expression of Borrelia burgdorferi infection-associated OspC and Erp surface proteins
15. Effects of environmental pH on membrane proteins in Borrelia burgdorferi
16. Expression of Borrelia burgdorferi OspC and DbpA is controlled by a RpoN-RpoS regulatory pathway
17. Altered stationary-phase response in a Borrelia burgdorferi rpoS mutant
18. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes
19. Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi
20. Borrelia burgdorferi-induced inflammation facilitates spirochete adaptation and variable major protein-like sequence locus recombination
21. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks
22. Analysis of Borrelia burgdorferi vlsE gene expression and recombination in the tick vector
23. Passive immunizing activity of sera from mice infected with Borrelia burgdorferi
24. Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B but not T cells alone
25. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA
26. Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi
27. T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of lyme disease
28. CD4+ T helper 1 cells facilitate regression of murine Lyme carditis
29. Early murine Lyme carditis has a macrophage predominance and is independent of major histocompatibility complex class II-CD4+ T cell interactions
30. Experimental lyme arthritis in the absence of interleukin-4 or gamma interferon
31. Interleukin-4 (IL-4) and IL-13 signaling pathways do not regulate Borrelia burgdorferi-induced arthritis in mice: IgG1 is not required for host control of tissue spirochetes
32. Gamma interferon is not required for arthritis resistance in the murine Lyme disease model
33. Cutting edge: T cell-mediated pathology in murine Lyme borreliosis
34. Cutting edge: Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2
35. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products
36. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2
37. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors
38. Toll-like receptors: Critical proteins linking innate and acquired immunity
39. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi
40. Genetic control of susceptibility to experimental Lyme arthritis is polygenic and exhibits consistent linkage to multiple loci on chromosome 5 in four independent mouse crosses
41. Genes outside the major histocompatibility complex control resistance and susceptibility to experimental Lyme arthritis
42. Bone-marrow chimeras reveal hemopoietic and non-hemopoietic control of resistance to experimental Lyme arthritis
43. An analysis of spirochete load, strain, and pathology in a model of tick-transmitted Lyme borreliosis
44. Impact of genotypic variation of Borrelia burgdorferi sensu stricto on kinetics of dissemination and severity of disease in C3H/HeJ mice
45. Borrelia burgdorferi gene expression in vivo and spirochete pathogenicity
46. Correlation between plasmid content and infectivity in Borrelia burgdorferi
47. Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1
48. Platelet activation by a relapsing fever spirochete results in enhanced bacterium-platelet interaction via integrin alphallbbeta3 activation
49. Identification of a candidate glycosaminoglycan-binding adhesin of the Lyme disease spirochete Borrelia burgdorferi
50. Variable small protein (Vsp)-dependent and Vsp-independent pathways for glycosaminoglycan recognition by relapsing fever spirochaetes
51. Delineation of Borrelia burgdorferi p66 sequences required for integrin alpha(llb)beta(3) recognition
52. Decorin-binding adhesins from Borrelia burgdorferi
53. Resistance to Lyme disease in decorin-deficient mice